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Dendritic spines represent the major site of neuronal activity in the brain; they serve as the receiving point for neurotransmitters and
undergo rapid activity-dependent morphological changes that correlate with learning and memory. Using a combination of homozy-
gosity mapping and next-generation sequencing in two consanguineous families affected by nonsyndromic autosomal-recessive intel-
lectual disability, we identified truncating mutations in formin 2 (FMN2), encoding a protein that belongs to the formin family of actin
cytoskeleton nucleation factors and is highly expressed in the maturing brain.We found that FMN2 localizes to punctae along dendrites
and that germline inactivation of mouse Fmn2 resulted in animals with decreased spine density; such mice were previously demon-
strated to have a conditioned fear-learning defect. Furthermore, patient neural cells derived from induced pluripotent stem cells showed
correlated decreased synaptic density. Thus, FMN2mutations link intellectual disability either directly or indirectly to the regulation of
actin-mediated synaptic spine density.Intellectual disability (ID), or early cognitive impairment,
is a common neurodevelopmental disorder that is esti-
mated to affect >1% of the population.1 Globally, ID re-
mains a healthcare challenge as well as a socioeconomic
burden in both developing and developed countries, and
it has immense effects on individuals and their families.
Although ID is defined by cognitive deficits (IQ < 70)
and limitations in adaptive behaviors (ICD-10), cases can
also be classified according to accompanying radiologic,
morphologic, and/or metabolic syndromes. When clas-
sification is made on the basis of such accompanying
syndromes, the disorder is known as syndromic ID (S-
ID); in the absence of other accompanying syndromes, it
is known as nonsyndromic ID (NS-ID [MIM 249500]).
Genetic heterogeneity, mode-of-inheritance heterogene-
ity, and gene-gene or gene-environment interactions in
NS-ID have made identification of causes difficult, but
more than 50 genes are now known to be mutated in a
biallelic fashion in autosomal-recessive ID (AR-ID).2,3
Accumulating evidence suggests that impaired synapse
formation and synaptic plasticity might underlie ID:
neuropathological examination of brains from affected
individuals consistently shows abnormalities in the den-
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The Americanmore, many of the NS-ID encoded proteins localize at or
near neuronal synapses, and most animal models show
defective synaptic structure or function. For instance, syn-
aptic spine morphological defects are linked with inactiva-
tion of murine Fmr1.5
Synaptogenesis initiates during human fetal life, peaks in
childhood, reaches a steady state in adolescence6 and for
some brain regions such as the hippocampus, continues
into adulthood. Modeling neurodevelopmental disease
with human induced pluripotent stem cells (hIPSCs) has
shown neuronal structural defects, including alterations in
synaptic density. For example, hIPSC ID models, including
those involving CDKL5 (MIM 300203) mutations, MECP2
(MIM 300005) mutations, and Down syndrome (MIM
190685), show reduced synaptic density,7–9 consistent
with defects in synapses as an underlying substrate.
In this study, we performed homozygosity mapping and
linkage analysis, followed by next-generation sequencing
in two independent, consanguineous ID-affected families
from Pakistan and Egypt. Participants were part of larger
cohorts originating from the Consortium for the Study
of Autosomal-Recessive Intellectual Disabilities (CARID).
These cohorts consisted of approximately 2,000 families,
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or more affected members with moderate to severe NS-ID,
presumed recessive in nature; exome sequencing was per-
formed or is being performed on most of these families.
Participants with major dysmorphism, structural brain
defects, syndromic features, metabolic derangements, or
demonstrable cytogenetic abnormalities were excluded.
The study was approved by the ethics committees of
the participating institutions, the procedures followed
were in accordance with the ethical standards of the
responsible committee on human experimentation (insti-
tutional and national), and proper informed consent was
obtained.
Extracted blood-derived DNA was subjected to a 5K SNP
array with the Illumina Linkage IVb mapping panel for all
informative members and analyzed with easyLinkage-
Plus software for calculation of multipoint LOD scores
(for ARID-628); the Affymetrix 500K Nsp GeneChip SNP
mapping panel was used for the three affected offspring
and one healthy offspring, and DNA was analyzed for
homozygosity with dCHIP and HomozygosityMapper
(for ARID-49, Figures 1A and 1D).10–12 ARID-628 demon-
strated the major linkage peak at chr1: q43–44, delin-
eated by rs1481141–rs6426327 (or chr1: 238,408,184–
246,089,811) (hg19), with a multipoint pLOD of 2.30,
which is similar to the predicted pLOD score13 (Figure S1
in the Supplemental Data available with this article
online). Several narrower peaks of similar significance
were located on other autosomes. ARID-49 demonstrated
two blocks of homozygosity, the major one delin-
eated by rs6702864–rs12137158 (or chr1: 230,161,767–
240,660,818) and another delineated by rs1019258–
rs7588049 (or chr2: 178,012,446–178,390,778) (Figure S2).
There was no shared haplotype between the two families,
and although the phenotypes were similarly severe with
respect to ID, there were some apparent differences.
Nevertheless, the two families shared a minimal candi-
date interval defined as chr1: 238,408,184–240,660,818,
or 2.25 Mb, containing three genes, CHRM2, FMN2,
and GREM2 (MIM 118493, 606373, and 608832, respec-
tively), and the long intergenic non-protein-coding RNA
LINC01139.
We generatedwhole-exome sequence for two affected in-
dividuals fromARID-628 and for one individual fromARID-
49 by using the Agilent SureSelect HumanAll Exome 50Mb
kit. We performed sequencing with an Illumina HiSeq2000
or ABI SOLiD 5500 instrument, resulting in ~94% recovery
at >103 coverage. GATK was used for SNP and INDEL
variant identification, and SeattleSeq was used for annota-
tion; variants were then filtered with >1% allele frequency
according to presence in dbSNP, the Exome Variant Server,
or in our in-house exome data set of more than 2,000
individuals. In addition, they were filtered if annotated
as benign according to functional prediction scores
(PolyPhen, Grantham, Phastcon, GERP).14,15 We analyzed
variants from both families with HomozygosityMapper to
confirm linkage intervals (Figures 1B and 1E).16 We tested
segregation of all exonic homozygous rare variants pre-722 The American Journal of Human Genetics 95, 721–728, Decembdicted to be deleterious, and we only report the variant as
causative if it is the single segregating variant. Affected
members of both families harbored a homozygous pre-
dicted frameshift variant in FMN2 (MIM606373), encoding
formin2 (FMN2) (Figures 1C and1F).None of the other var-
iants considered as candidates showed patterns consistent
with a recessive mode of inheritance for affectation status
(Tables S1 and S2).
ARID-628 was recruited from Lower Egypt as a consan-
guineous pedigree with two affected members, aged 16
and 14 years (Table 1). The children were delivered at
term but experienced delayed milestones, primarily in
cognition and speech, whereas gross-motor and fine-motor
development were not as dramatically affected. IQ was
50–60, tested in the teenage years, and both children
remain illiterate past adolescence and speak in only 1–2
word phrases. Independent gait was obtained at 2 years.
Rare partial complex seizures developed at age 10 years,
controlled with carbamazepine. The older individual has
a history of asymptomatic mitral valve prolapse. ARID-49
was recruited from a remote village in Azad Jammu and
Kashmir, Pakistan as a consanguineous pedigree with three
affected members, aged 30, 25, and 17 years, and three
healthy siblings. All were born after normal pregnancies.
Individual IV-1 was independent in self-care, and speech
was well developed, but he was unable to read or write
and has never been gainfully employed. He frequently dis-
appeared from home for days at a time, wandered in the
local area, and functioned in the mildly intellectually
disabled range. The other two affected members never
developed speech beyond 2 or 3 word phrases, nor reading
or writing, and were unable to care for themselves. There
were no hearing or visual impairments evident and no his-
tory of seizures. For both families, no dysmorphic features
were noted, and occipital frontal head circumference was
within the normal range. MRI and EEG analyses were
normal in one affected member.
The putative causative variant in ARID-628 was in
the first exon and was annotated in hg19 as chr1:
240,256,799insG, a single G nucleotide insertion, predict-
ing a frameshift at amino acid 466 of 1,726 residues
(c.1394_1395insC [p.Ala466Glyfs*483], RefSeq transcript
NM_020066.4). The variant in ARID-49 was in the fifth
constitutive exon, chr1:240,370,627delA, a single A nucle-
otide deletion, predicting a frameshift at amino acid 839
(c.2515_2515delA [p.Thr839Argfs*848], RefSeq transcript
NM_020066.4). We confirmed both variants with Sanger
sequencing, and additionally confirmed that the variants
segregated according to a strict recessive model with full
penetrance. The ARID-49 variant occurred on the minor
allele of a common synonymous SNP, rs10926166, and
thus sequences were compared with two different healthy
individuals, one displaying the major and one displaying
the minor allele (Figures 1C and 1F). Neither frameshifting
variant was predicted to affect several shorter FMN2 tran-
script variants (from mRNAs AK297755 and AK298141,
derived from coronary artery smooth muscle cells ander 4, 2014
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Figure 1. ARID-628 and ARID-49 with Homozygous Inactivating Mutations in FMN2
(A and D) Consanguineous parents and multiple affected individuals suggest recessive inheritance.
(B and E) Homozygous exome haplotypes containing FMN2 in telomeric chromosome 1 (arrows).
(C and F) ARID-628 homozygous chr1:240,256,799insG (arrow) and ARID-49 showing major-allele control TTCAAACGA, minor-allele
control (MA) TTCAAACCA, and diseased TTCAACGA (arrow) chr1:240,370,627delA.
(G) Genomic organization and location of mutations for chr1q43–44, including FMN2, from the UCSC Genome Browser; mutations are
not predicted to interfere with shorter transcripts.
(H) FMN2 encodes a 1,726 residue protein with DEP, FH1, and FH2 domains, several putative sites of phosphorylation (small vertical
ticks), and an FMN2-SPIRE1-interacting domain (FSI).
(I) RT-PCR of FMN2 primary fibroblasts shows that products are absent in IV-4 but present in the control (C), III-2, and GAPDH
fibroblasts, suggesting nonsense-mediated decay. Primer sequencing: FMN2-F, 50-CCGTCTCAGTCCCCTAATCA-30; FMN2-R, 50-
ATCCGGGAGCAAAACTTCTC-30; GAPDH-F, 50-ATCCCATCACCATCTTCCAG-30; and GAPDH-R, 50-CCATCACGCCACAGTTTCC-30.
(J) An immunoblot of FMN2 in primary fibroblasts shows an absence of protein in IV-4 but presence in the control, III-2. GAPDH was
used as a loading control. Antibodies: FMN2, Sigma HPA004937, 1:1,000; and GAPDH, Millipore mab374, 1:5,000.
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Table 1. Clinical Description of Affected Individuals from Families ARID-628 and ARID-49
ARID-628-IV-4 ARID-628-IV-5 ARID-49-IV-1 ARID-49-IV-2 ARID-49-IV-3
Family Information
Consanguineous þ þ þ þ þ
Multiplex þ þ þ þ þ
Number of affected
individuals
2 2 3 3 3
Extended family history
of ID and/or epilepsy
þ þ - - -
Clinical Information
Age at examination 16 years 14 years 30 years 25 years 17 years
Sex female male male female female
Intellectual disability þ þ þ þ þ
Speech 1–2 words 1–2 words full sentences 2–3 words single words
Hearing normal normal normal normal normal
Daily activities (eating,
toilet)
dependent dependent Independent dependent dependent
Dysmorphic facies - - - - -
Hypotonia þ þ - - -
Microcephaly - - - - -
Seizures (partial complex) controlled controlled - - -
Electroencephalogram normal N/A N/A N/A N/A
Medication Carbamazepine Carbamazepine
Spasticity - - - - -
Visual abnormalities - - - - -
Head circumference 52.4 cm 50.3 cm 51.7 cm 51.6 cm 50.4 cm
Other systemic features mitral valve prolapse - - - -
Brain MRI normal N/A N/A N/A normal
Homozygous mutation
(hg19 coordinates)
chr1:240,256,799insG chr1:240,256,799insG chr1:240,370,627delA chr1:240,370,627delA chr1:240,370,627delA
cDNA mutation
(NM_020066.4)
c.1394_1395insC c.1394_1395insC c.2515_2515delA c.2515_2515delA c.2515_2515delA
Protein alteration
(NP_064450.3)
p.Ala466Glyfs*483 p.Ala466Glyfs*483 p.Thr839Argfs*848 p.Thr839Argfs*848 p.Thr839Argfs*848
N/A indicates ‘‘not assessed.’’synoviocytes, respectively (Figure 1G), when alternative
start sites were used. The variants were not identified in
any other individuals from more than 3,000 whole-exome
sequences, in 200 healthy control geographically matched
individuals, or in any public database. There were no other
potentially deleterious FMN2 variants in the CARID data-
base or in private databases consisting of more than
4,000 intellectually disabled individuals who underwent
exome sequencing.
The NHLBI study identified several different potentially
deleterious variants in the database of >4,000 individuals,
but none argued strongly against FMN2 as a potential cause
of ID in these families. The rs375865107 variant predicts724 The American Journal of Human Genetics 95, 721–728, Decembp.Trp601* and was found to be heterozygous in one of
6,502 individuals, and the chr1:240286646_240286647insT
(RefSeq accession number NM_020066.4; c.1782þ1_
1782þ2insT) variant was found to be heterozygous
in one of 6,295 individuals; probably both variants
are valid. However, the chr1:240371554_240371558del5
(RefSeq NM_020066.4; c.3442_3446del5) variant, pre-
dicting p.Arg1148Glyfs*103, and the chr1:240371609_
240371610insT (RefSeq NM_020066.4; c.3497_3498insT)
variant, predicting p.Leu1168Serfs*85, have average read
depth below 10 and were far outside of Hardy-Weinberg
equilibrium (p value < 1 3 10311), and the latter occurred
ina stretchofhomocytosines.Nonewere found inanyotherer 4, 2014
public databases (or in our internal database), suggesting
sequencing errors. Finally, several variants, including
rs141879002, rs370558399, rs142397272, rs147210965,
rs199721402, rs146873580, rs374743076, rs150801382,
and rs183078344, modify well-conserved residues, but
none are homozygous in any retrievable database.
To investigate the effect of the mutation on mRNA and
protein, we tested expression of FMN2 in control lympho-
cytes but were unable to detect any expression, precluding
analysis from family ARID-49, where only lymphocytes
were available. Thus, skin biopsy was obtained from family
ARID-628, RNA was reverse transcribed, and primers were
designed to span coding exons. FMN2 encodes a 1,726
amino acid polypeptide as the major isoform (Figure 1H).
We amplified a 398 bp product in control and III-2 individ-
uals but no product in affected member IV-4, consistent
with mRNA nonsense mediated decay, whereas GAPDH
amplified a 383 bp product similarly in the three individ-
uals (Figure 1I). Total cellular protein from confluent fibro-
blasts was analyzed by SDS-PAGE and blotted with a
commercial FMN2 antibody, yielding a 195 Kd protein in
control and III-2 individuals but no product in affected
member IV-4, whereas GAPDH yielded similar band inten-
sities in all (Figure 1J). We conclude that the ARID-628
mutation results in the absence of detectable full-length
protein in cells from the affected individual.
FMN2 is one of 15 formin proteins identified in humans.
Its identification is based upon the presence of a catalytic
actin-nucleating and polymerizing formin homology
2 (FH2) domain.17 FMN2 additionally encodes a DEP
(Dishevelled, Egl-10, and Pleckstrin) domain, suggesting
a role in G-protein-coupled receptor signaling; a proline-
rich FH1 domain; a formin-Spire1 interaction (FSI)
domain18 involved in actin nucleation; and several phos-
phorylation sites, which probably regulate its activity.
FMN2 has 18 exons, encodes three major isoforms, and is
predicted to have important roles in actin cytoskeletal or-
ganization and the establishment of cellular polarity.
Although FMN2 is expressed predominantly in the devel-
oping and mature brain,19 Fmn2 knockout mice (Neo
cassette replacing 433 amino acids at the FH1 domain,
Jackson labs, stock #016264, maintained on a pure
129S6/SvEvTac background) survive without major defects
and have neither gross nor histological brain differences
when they are compared with littermates.19 Fmn2/
germline female mutant mice show decreased fertility
and abnormal positioning of the metaphase spindle and
formation of the first polar body during oogenesis, but
males show no corresponding defect.20 Alhough FMN2
overexpression in NIH 3T3 cells showed dramatic disrup-
tion of the actin and microtubule network,21 we noted
no major cellular morphology defect in FMN2 mutant
fibroblasts under basal growth conditions.
Fmn2 was identified a ‘‘learning-regulated gene’’ as part
of a screen for genes that were upregulated and for which
H4K12 acetylation of the coding region increased upon
fear conditioning in 3-month-old but not 16-month-oldThe Americanmice. Furthermore, Fmn2/ 8-month-old but not 3-
month-old mice showed impaired associative learning,
whereas pain sensation, explorative behavior, and basal
anxiety were similar among groups.22 Because fear condi-
tioning is hippocampal dependent, we studied FMN2 in
the hippocampus at P14 in home-cage-reared mice and
found that the protein within the granule neuron den-
dritic tree colocalized with the actin cytoskeleton, on the
basis of phalloidin colocalization; as a control, we found
no staining in Fmn2/ mice (Figure 2A). Hippocampal
neuroanatomy was grossly intact, arguing against a role
for Fmn2 in neuronal migration or differentiation.
Most CNS excitatory synapses are located on small
membrane protrusions called dendritic spines, in which a
dynamic F-actin matrix is linked to postsynaptic-density
scaffold proteins, signaling proteins, and NMDA and
AMPA receptors. Actin dynamics are of great importance
for synaptic plasticity andmemory formation, and formins
have been proposed as candidates for regulating the nucle-
ation and polymerization of actin filaments in dendritic
filopodia. In fact, the formin member mDia2 localizes to
hippocampal synaptic spines, and knockdown results in
altered spine morphology.23 In cultured murine primary
hippocampal neurons, we found partially adjacent and
overlapping protein localization between FMN2 and
the postsynaptic-density marker PSD95 and the presynap-
tic markers VGLUT1 and SYNAPSIN, suggesting that
FMN2 also localizes to intracellular sites nearby spines
(Figure 2B), although determining precise subspine
compartmental localization will require additional work.
To determine whether Fmn2 is required for the
morphology of hippocampal dendritic spines, we per-
formed Golgi staining in P47 wild-type mice and their
Fmn2/ littermates, then measured spine density. We
found that overall neuronal architecture was intact and
that there were no notable differences in dendritic branch-
ing or length. However, dendritic spines were reduced in
density by 32% on mutant hippocampal dentate granule
neurons (Figures 2C–2E). We conclude that hippocampal
dendritic-spine density is reduced in Fmn2/ mice.
To determine whether this defect in synaptic density
occurred in human cells, we reprogrammed fibroblasts
from one diseased and one healthy member of ARID-628
and a healthy age- and sex-matched control by using inte-
gration-free episomal methods,24 excluded gross chromo-
somal postreprogramming rearrangements, and generated
neural cells by using a dual-SMAD inhibition protocol.25
There was no defect noted in the efficiency of reprogram-
ming or in the formation of neural rosettes, neural precur-
sor cells (NPCs), or mature neuronal cells (Figure S3A), nor
was any defect noted in the differentiation of hIPSCs into
mesodermal or endodermal lineages (Figure S3B), suggest-
ing that the hIPSCs reprogrammed fully and generated
healthy neural cells. In neurons cultured for 4 weeks, there
were no defects in survival, differentiation, dendritic
complexity, or nuclear morphology among the three lines.
We subsequently stained neural cells for F-actin andJournal of Human Genetics 95, 721–728, December 4, 2014 725
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Figure 2. FMN2 Is Required for Dendritic-
Spine Morphogenesis in Mice
(A) P14 hippocampus from Fmn2þ/þ and
Fmn2/. Immunofluorescence showed
FMN2 staining in the granule neuron den-
dritic region (the highlighted section is
the CA2 region) of Fmn2þ/þ mice but no
staining in knockout mice. Phalloidin
staining was not overtly different between
genotypes. The scale bar represents
150 mm.
(B) FMN2 punctae localize along
dendrites of cultured murine primary hip-
pocampal neurons at 21 days in vitro.
Staining was adjacent to both post-
(PSD-95) and pre-synaptic (VGLUT1 and
SYNAPSIN) markers but did not fully
colocalize. The scale bar represents
5 mm. FMN2: Sigma HPA004937, 1:200.
PSD95 Thermo MA1-045, VGLUT1 Syn-
aptic Systems, Inc. #135302, SYNAPSIN
Cell Signaling #5297.
(C and D) Golgi-stained images of Fmn2þ/þ
and Fmn2/ are shown at low and high
magnification (FDneurotech Rapid Golgi
Stain method). Neuronal morphology was
indistinguishable, but spine density was
reduced in knockout neurons when Sholl’s
method for dendritic arborization was
used. The scale bars in (D) and (E) represent
50 mm; in (D0) and (E0) it represents 20 mm.
(E) Quantification of spine density per
micron of dendrite of hippocampal granule
neuron from the CA2 region from three mice of each genotype, two sections per animal, >1,000 spines per animal. *p < 0.001 by Stu-
dent’s t test. The error bar shows SEM (0.805 0.05 versus 0.545 0.04 spines/mm, n ¼ 3 mice of each genotype).VGlut1 in order to identify excitatory synapses (Figure S4),
then segmented punctae to determine synaptic density
(Figure 3A). We found that synaptic density in diseased
cells was reduced by 43% in comparison with healthy con-
trols (Figure 3B), suggesting reduced synaptic density in
human IPSC-derived neural cells in the absence of FMN2.
In summary, we report homozygous truncating muta-
tions in FMN2 as a cause of autosomal-recessive nonsyn-
dromic ID. The work is corroborated by an absence of
protein in cells from affected members, by study of expres-
sion and localization of the endogenous gene and protein
in mice, by synaptic spine defects in knockout mice, and
by synaptic density defects in mutant human neural cells.
We suggest that FMN2 might be required for regulation of
the actin cytoskeleton during spine development, matura-
tion, or remodeling. Previously, two individuals with de
novo interstitial deletions involving FMN2, among other
genes, demonstrated intellectual disability,26,27 suggesting
that haploinsufficiency, perhaps in combination with
other gene deficiencies, might similarly correlate with ID.
Mutations in other FH2-domain-containing proteins
have been implicated in human disease: for example, mu-
tations in INF2 (MIM 610982) cause autosomal-dominant
intermediate Charcot-Marie-Tooth disease type E (MIM
614455) and dominant focal segmental Glomerulosclero-
sis type 5 (MIM 613237), and mutations in DIAPH2
(MIM 300108) cause X-linked premature ovarian failure
(MIM 200511). Recently, a biallelic null mutation in726 The American Journal of Human Genetics 95, 721–728, DecembDIAPH1 (MIM 602121), encoding a diaphanous-related
formin-family-of-Rho effector protein, was identified in a
family affected by microcephaly.28 FMN1 (MIM 136535)
shows embryonic expression,29 targeted deletion in mouse
shows oligodactylism and alters BMP signaling,30 and a
genomic rearrangement including FMN1 shows non-
syndromic oligosyndactyly.31 FMN2 now joins a group of
genes implicated in neuronal functions mediating higher
cognition in humans.Supplemental Data
Supplemental Data include four figures and two tables and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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Figure 3. Reduced Synaptic Density in Human FMN2 Mutant
IPSC-Derived Neural Cells
(A) FMN2 mutant cells exhibit reduced density of excitatory syn-
apses as assessed by VGlut1 (green) staining of neural cells (see
also Figure S4). F-actin was visualized via phalloidin staining (red).
(B) Quantification of excitatory synapses per square micron
showed reduced density in cells from affected members specif-
ically under the Imaris MeasurementPro module. *p < 0.01 by
Student’s t test. The error bar represents SEM (0.835 0.085 versus
0.815 0.065 versus 0.475 0.110 in the control individual, unaf-
fected individual, and affected individual, respectively; n ¼ 10
dendrites segmented from each of four neurons from two inde-
pendent cultures per individual).support, the Consortium for Autosomal Recessive Intellectual
Disability (CARID) for supporting ascertainment, and Katie Hsiao
(Nathanial Heintz lab) for sharing hippocampal cultures.
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The URLs for data presented herein are as follows:
NHLBI Exome Sequencing Project (ESP) Exome Variant Server,
http://evs.gs.washington.edu/EVS/
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.org/
PolyPhen-2, www.genetics.bwh.harvard.edu/pph2/
Quantsmooth,http://www.bioconductor.org/packages/release/bioc/
html/quantsmooth.html
RefSeq, http://www.ncbi.nlm.nih.gov/RefSeq
SeattleSeq,http://snp.gs.washington.edu/SeattleSeqAnnotation137/Accession Numbers
RefSeq NCBI transcript FMN2: NM_020066.4
Exome data for ARID-628 have been deposited into dbGaP
(phs000288).References
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